April 23, 2003
Pharmacia Has Recalled Zyvox oral suspension
The Food and Drug
Administration (FDA) released the following information.
Zyvox oral suspension (linezolid for oral suspension), 100 mg/5 ml, 150 ml (when constituted), Rx only. Recall # D-214-3.
Lots 11HKU, 97HAH, 82HHW, 16HXK, 61JBC, 94JAM, 08HDC, 10HHM, 22HFC, 63HJD, 64HJD, 11HMC, 12HMC, 34HMC, 75HKU, 86HMJ, 14JAH, 15JAH, 18HXP, 19HXP, 21HXP, 22HXP, 31JAK, 53JAY, 59JBC, 76HXP, 77HXK, 91HYT,and 96HWY.
Pharmacia Corporation, Kalamazoo, MI, by letters dated March 18, 2003. Firm initiated recall is ongoing.
VOLUME OF PRODUCT IN COMMERCE
Nationwide and Austria, Australia, Barbados, Belgium, China, Equador, Germany, Greece, Hong Kong, India, Ireland, New Zealand, Qatar, Russia, Singapore, South Africa, Spain, Sri Lanka, Switzerland, and the United Kingdom.